150 related articles for article (PubMed ID: 38714634)
1. Implications of Low-concentration Polymer on the Physical Stability of Glassy Griseofulvin: Role of the Segmental Mobility.
Wang Y; Chin CY; Shivashekaregowda NKH; Shi Q
AAPS PharmSciTech; 2024 May; 25(5):103. PubMed ID: 38714634
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of Crystal Growth of Amorphous Griseofulvin by Low-Concentration Poly(ethylene oxide): Aspects of Crystallization Kinetics and Molecular Mobility.
Shi Q; Zhang C; Su Y; Zhang J; Zhou D; Cai T
Mol Pharm; 2017 Jul; 14(7):2262-2272. PubMed ID: 28548840
[TBL] [Abstract][Full Text] [Related]
3. Impact of Polymer Enrichment at the Crystal-Liquid Interface on Crystallization Kinetics of Amorphous Solid Dispersions.
Zhang J; Shi Q; Tao J; Peng Y; Cai T
Mol Pharm; 2019 Mar; 16(3):1385-1396. PubMed ID: 30716277
[TBL] [Abstract][Full Text] [Related]
4. Fast surface crystallization of amorphous griseofulvin below T g.
Zhu L; Jona J; Nagapudi K; Wu T
Pharm Res; 2010 Aug; 27(8):1558-67. PubMed ID: 20414704
[TBL] [Abstract][Full Text] [Related]
5. Glass Transition Dynamics and Physical Stability of Amorphous Griseofulvin in Binary Mixtures with Low-
Tu W; Knapik-Kowalczuk J; Chmiel K; Paluch M
Mol Pharm; 2019 Aug; 16(8):3626-3635. PubMed ID: 31287704
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mobility and Crystal Growth in Amorphous Binary Drug Delivery Systems: Effects of Low-Concentration Poly(Ethylene Oxide).
Shi Q; Cheng J; Li F; Xu J; Zhang C
AAPS PharmSciTech; 2020 Nov; 21(8):317. PubMed ID: 33175339
[TBL] [Abstract][Full Text] [Related]
7. Influence of PVP/VA copolymer composition on drug-polymer solubility.
Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
Eur J Pharm Sci; 2016 Mar; 85():10-7. PubMed ID: 26826280
[TBL] [Abstract][Full Text] [Related]
8. Low-concentration polymers inhibit and accelerate crystal growth in organic glasses in correlation with segmental mobility.
Powell CT; Cai T; Hasebe M; Gunn EM; Gao P; Zhang G; Gong Y; Yu L
J Phys Chem B; 2013 Sep; 117(35):10334-41. PubMed ID: 23909486
[TBL] [Abstract][Full Text] [Related]
9. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.
Matsumoto T; Zografi G
Pharm Res; 1999 Nov; 16(11):1722-8. PubMed ID: 10571278
[TBL] [Abstract][Full Text] [Related]
10. The effects of absorbed water on the properties of amorphous mixtures containing sucrose.
Shamblin SL; Zografi G
Pharm Res; 1999 Jul; 16(7):1119-24. PubMed ID: 10450941
[TBL] [Abstract][Full Text] [Related]
11. Molecular mobility in glassy dispersions.
Mehta M; McKenna GB; Suryanarayanan R
J Chem Phys; 2016 May; 144(20):204506. PubMed ID: 27250315
[TBL] [Abstract][Full Text] [Related]
12. Effects of Polymers on Cocrystal Growth in a Drug-Drug Coamorphous System: Relations between Glass-to-Crystal Growth and Surface-Enhanced Crystal Growth.
Luo M; Chen A; Huang C; Guo M; Cai T
Mol Pharm; 2024 Jul; 21(7):3591-3602. PubMed ID: 38818946
[TBL] [Abstract][Full Text] [Related]
13. Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc.
Sun Y; Tao J; Zhang GG; Yu L
J Pharm Sci; 2010 Sep; 99(9):4023-31. PubMed ID: 20607809
[TBL] [Abstract][Full Text] [Related]
14. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
[TBL] [Abstract][Full Text] [Related]
15. Characterization and stability of ternary solid dispersions with PVP and PHPMA.
Al-Obaidi H; Ke P; Brocchini S; Buckton G
Int J Pharm; 2011 Oct; 419(1-2):20-7. PubMed ID: 21801822
[TBL] [Abstract][Full Text] [Related]
16. Fast Surface Diffusion and Crystallization of Amorphous Griseofulvin.
Huang C; Ruan S; Cai T; Yu L
J Phys Chem B; 2017 Oct; 121(40):9463-9468. PubMed ID: 28885850
[TBL] [Abstract][Full Text] [Related]
17. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
Wang B; Wang D; Zhao S; Huang X; Zhang J; Lv Y; Liu X; Lv G; Ma X
Eur J Pharm Sci; 2017 Jan; 96():45-52. PubMed ID: 27568852
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two DSC-based methods to predict drug-polymer solubility.
Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
Int J Pharm; 2018 Apr; 540(1-2):98-105. PubMed ID: 29425764
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.
Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
Mol Pharm; 2008; 5(6):927-36. PubMed ID: 19434849
[TBL] [Abstract][Full Text] [Related]
20. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
Bochmann ES; Neumann D; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
